China coronavirus: mild but infectious cases may make it hard to control outbreak, report warns.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Impact of the COVID-19 pandemic on endoscopic procedures: a single-center study in China.World journal of emergency medicine · 2022
   Article
2. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review).Molecular medicine reports · 2021
   Article
3. Epidemiologic characteristics and influencing factors of cluster infection of COVID-19 in Jiangsu Province.Epidemiology and infection · 2021
   Article
4. Clinical characteristics of inpatients with coronavirus disease 2019 (COVID-19) in Sichuan province.BMC infectious diseases · 2021
   Article
5. Safety of ACE-I and ARB medications in COVID-19: A retrospective cohort study of inpatients and outpatients in California.Journal of clinical and translational science · 2021
   Article
6. Spatiotemporal analysis and the characteristics of the case transmission network of 2019 novel coronavirus disease (COVID-19) in Zhejiang Province, China.PloS one · 2021
   Article
7. SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution.ACS central science · 2020
   Article
8. COVID-19: A review of what radiologists need to know.World journal of clinical cases · 2020
   Review
9. The COVID-19 Infodemic: Infodemiology Study Analyzing Stigmatizing Search Terms.Journal of medical Internet research · 2020
   Article
10. Management of an endoscopy center during the outbreak of COVID-19: Experience from West China Hospital.World journal of gastroenterology · 2020
    Article
11. COVID-2019 - A comprehensive pathology insight.Pathology, research and practice · 2020
    Review
12. Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice.Clinical reviews in allergy & immunology · 2020
    Review
13. Uncertainties about the transmission routes of 2019 novel coronavirus.Influenza and other respiratory viruses · 2020
    Article
14. Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China.Transboundary and emerging diseases · 2020
    Article
15. C-reactive protein levels in the early stage of COVID-19.Medecine et maladies infectieuses · 2020
    Article
16. [Interval between entry of mainland China and diagnosis in imported COVID-19 cases and factors contributing to delayed diagnosis in Guangdong Province].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
17. Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China.JCI insight · 2020
    Article
18. Exposure to coronavirus (COVID-19) using narrative and simulated experience approaches: A commentary.Journal of education and health promotion · 2020
    Article
19. Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism.Neuropsychiatric disease and treatment · 2020
    Review
20. Evidence-Based Framework and Implementation of China's Strategy in Combating COVID-19.Risk management and healthcare policy · 2020
    Article

Corrections and comments

• Commented on by
  Uncertainties about the transmission routes of 2019 novel coronavirus.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.